Atw Spac Management »

Conduit Pharmaceuticals shares owned by Atw Spac Management

Quarter-by-quarter ownership of Conduit Pharmaceuticals (CDTTW) shares owned by Atw Spac Management from 13F filings

Historical chart of Atw Spac Management investment in Conduit Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Conduit Pharmaceuticals held by Atw Spac Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Conduit Pharmaceuticals by Atw Spac Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $11k 250k 0.05

More positions owned by Atw Spac Management

Monterey Cap Acquisition Cor Class A Com (MCAC)
Denali Capital Acquisitn Cor Class A Ord (DECA)
Alphatime Acquisition Corp Ordinary Shares (ATMC)
Burtech Acquisition Corp Class A Com (BRKH)
Pono Cap Three Ord Shs Cl A
Trailblazer Merger Corp I Cl A (TBMC)
Bellevue Life Scncs Aqstn (BLAC)
99 Acquisition Group Unit 99/99/9999 (NNAGU)
Cetus Cap Acquisition Corp Class A Com (CETU)
Distoken Acquisition Corp Ordinary Shares (DIST)
Arisz Acquisition Corp Common Stock
Esh Acquisition Corp (ESHA)
Keen Vision Acquisition Corp SHS (KVAC)
Bukit Jalil Gbl Acquisition Ord Shs (BUJA)
Pearl Holdings Acquisitn Cor Class A Ord Shs (PRLH)

View all positions for Atw Spac Management

Top funds holding Conduit Pharmaceuticals

Highbridge Capital Management
Polar Securities
Saba Capital Management
MMCAP International Inc. SPC
Exos TFP Holdings
Walleye Trading Advisors
D. E. Shaw & Co
Walleye Trading
Wolverine Asset Management
CNH Partners
Cowen And Company
Whitebox Advisors
Rivernorth Capital Management
Context Capital Management
Kim

View all funds holding Conduit Pharmaceuticals